Tag: field

Jerusalem and Milan, July 11, 2025 (8:30 AM CET) – Solargik, a global pioneer in photovoltaic terrain-adaptive energy solutions today announced the signing of 85 megawatts (MW) in new utility-scale solar projects across Italy, marking a significant step in opening up solar deployment in areas long considered too steep, constrained, or regulated for viable installation in Europe.

The surge in Bitcoin's price has brought more attention and investment opportunities. With DRML Miner, miners and investors can more efficiently participate in this lucrative field. As the market continues to develop, a greater focus on mining efficiency and flexibility will be the key to future success.

SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced the administration of the first dose of troculeucel, an expanded autologous NK cell therapy, under a single compassionate use, Investigational New Drug (“IND”) authorization cleared by the U.S. Food and Drug Administration (“FDA”), to a patient with mild-stage Alzheimer’s disease who exhibited continued cognitive decline despite ongoing treatment with lecanemab, an amyloid targeting therapy. This exploratory work is being conducted in collaboration with Anita Fletcher, M.D., a board-certified neurologist with specialized training in neuroimmunology, who also serves as Director of Neuroscience Clinical Research at AdventHealth Neuroscience Institute in Orlando, Florida.